Prospect News: News for Laboratory Corp. of America Holdings (LabCorp)

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with L > Issuers starting with L, CV only > All stories on Laboratory Corp. of America Holdings (LabCorp) > Stories on Laboratory Corp. of America Holdings (LabCorp), CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Laboratory Corp. of America Holdings (LabCorp)

10/1/2018	CV	LabCorp says 0% notes due 2021 remain convertible through December
10/12/2016	CVIG	Moody’s ups LabCorp view to stable
11/3/2014	CV	Market Commentary: American Realty bonds take another leg lower; Omnicare higher; Owens-Illinois sets tender
11/3/2014	CVIG	S&P puts LabCorp on watch
11/3/2014	CV	Market Commentary: Morning Commentary: American Realty moves lower; LabCorp shares down on acquisition news
10/1/2014	CV	LabCorp says zero-coupon notes now convertible through December
9/12/2014	CV	LabCorp: 0% convertibles accrue contingent cash interest to March 11
7/1/2014	CV	LabCorp says zero-coupon notes now convertible through September
4/1/2014	CV	LabCorp's zero-coupon notes now convertible through June 30
3/11/2014	CV	LabCorp says zero-coupon convertibles to accrue interest to Sept. 11
12/13/2013	CVIG	S&P upgrades LabCorp to BBB+
10/29/2013	CVIG	Moody's rates LabCorp notes Baa2
10/29/2013	CVIG	S&P assigns LabCorp notes BBB
10/1/2013	CV	LabCorp holders may now convert zero-coupon notes through year-end
9/12/2013	CV	LabCorp says zero-coupon convertibles to accrue interest to mid-March
7/1/2013	CV	LabCorp holders may convert zero-coupon notes through Sept. 30
4/8/2013	CV	LabCorp holders may convert zero-coupon notes through June 28
3/25/2013	CVIG	Moody's: LabCorp view stable
3/11/2013	CV	LabCorp 0% convertibles accrue contingent cash interest to Sept. 11
1/9/2013	CVIG	S&P lowers LabCorp
1/2/2013	CV	LabCorp holders may convert zero-coupon notes through March 29
10/1/2012	CV	LabCorp holders may convert zero-coupon notes due 2021 through Dec. 31
9/12/2012	CVLM	LabCorp to pay $1.48 contingent cash interest on convertibles due 2021
8/20/2012	CVIG	Moody's rates LabCorp notes Baa2
8/20/2012	CVIG	S&P rates LabCorp notes BBB+
8/17/2012	BKCVIG	Moody's LabCorp view positive
7/2/2012	CV	LabCorp announces conversion right for 0% notes through Sept. 18
4/2/2012	CVLM	LabCorp's zero-coupon notes now convertible through June 29
3/13/2012	CV	Laboratory Corp. of America's convertibles to accrue cash interest
1/3/2012	CVLM	LabCorp says 0% notes convertible for another quarter through March
12/9/2011	CVIGPF	Laboratory Corp. files automatic shelf for debt, preferreds and stock
10/6/2011	CV	LabCorp says zero-coupon notes remain convertible for another quarter
9/13/2011	CV	LabCorp 0% convertibles accrue contingent cash interest to March 11
9/12/2011	CVLM	LabCorp holders put back no 0% convertible subordinated notes due 2021
7/1/2011	CV	LabCorp holders may continue to convert 0% notes for three more months
4/4/2011	CV	LabCorp's 0% convertible notes due 2021 are convertible to June 30
3/14/2011	CVLM	LabCorp to pay contingent cash interest on 0% convertibles due 2021
1/3/2011	CV	LabCorp's 0% convertible subordinated notes due 2021 are convertible
11/16/2010	CVIG	S&P rates LabCorp notes BBB+
11/16/2010	CVIG	Moody's rates LabCorp notes Baa2
10/4/2010	CV	LabCorp's 0% convertible subordinated notes due 2021 are convertible
9/14/2010	CVIG	Moody's drops LabCorp outlook to stable
9/13/2010	CV	LabCorp's 0% convertible notes due 2021 to accrue contingent interest
9/13/2010	BWCVIG	LabCorp to use revolver, bonds for $925 million acquisition of Genzyme
7/1/2010	CV	LabCorp's 0% convertible subordinated notes due 2021 are convertible
6/4/2010	CVIG	Moody's upgrades LabCorp
4/6/2010	CV	LabCorp 0% subordinated notes due 2021 convertible into cash, stock
3/26/2010	CV	LabCorp convertibles to accrue contingent cash interest to Sept. 11
1/5/2010	CV	LabCorp 0% convertible subordinated notes conversion rights triggered
9/21/2009	CVIG	Moody's ups LabCorp outlook to positive
8/20/2009	CVIG	S&P boosts LabCorp
7/1/2009	CV	LabCorp redeems all remaining LYONs, half of zero-coupon convertibles
6/30/2009	CVIG	S&P: LabCorp on positive watch
5/12/2009	CVIG	Moody's: LabCorp unchanged
5/11/2009	CV	LabCorp calls all remaining LYONs, half of remaining 0% convertibles for redemption
3/6/2009	CV	Market Commentary: Financials, Wells Fargo weak, but in line with stock; Qwest adds 0.25 point; LabCorp finds buyers
12/5/2008	CVIG	Laboratory Corp. of America files automatic shelf
10/1/2008	CV	LabCorp's LYONs, 0% convertibles remain convertible in fourth quarter
9/12/2008	CV	LabCorp to pay contingent interest on LYONs, 0% convertibles
7/1/2008	CV	LabCorp's notes due 2021 remain convertible
4/1/2008	CV	LabCorp announces LYONs, 0% convertibles remain convertible through second quarter
3/12/2008	CV	LabCorp holders to receive contingent interest on LYONs, 0% convertibles
1/4/2008	CV	LabCorp says holders may convert LYONs, 0% convertibles in fourth quarter
10/26/2007	CVIG	S&P affirms LabCorp
10/26/2007	CVIG	Moody's affirms LabCorp
10/3/2007	CV	Holders may convert LabCorp. LYONs, 0% convertibles for fourth quarter
9/12/2007	CV	LabCorp LYONs, zero-coupon convertibles to pay contingent interest
7/24/2007	CV	LabCorp says holders may convert LYONs, 0% convertibles for third quarter
4/16/2007	CV	LabCorp says holders may convert LYONs, 0% convertibles in second quarter
3/19/2007	CV	LabCorp LYONs, zero-coupon convertibles to pay contingent interest
1/9/2007	CV	LabCorp says holders may convert LYONs, 0% convertibles in first quarter
10/23/2006	BTCV	LabCorp exchanges 99% of LYONs due 2021
10/2/2006	BTCV	LabCorp says LYONs due 2021 will be convertible for fourth quarter
9/22/2006	BTCV	LabCorp starts net share settlement exchange offer for LYONs due 2021
9/22/2006	BTCV	LabCorp noteholders put $34,000 LYONs
9/19/2006	BTCV	LabCorp LYONs to pay contingent interest
1/18/2006	CV	Market Commentary: Techs dominate convertibles market; Intel drops outright but expands on a hedged basis, AMD adds
1/5/2006	CV	Market Commentary: Convertible market extends broad-based gains; autos, biotechs lift; Fannie Mae adds
12/8/2005	BKBTCV	S&P rates LabCorp notes BBB
12/8/2005	CV	Market Commentary: New SafeNet convertibles gain with shares; technology and biotech firmer; LabCorp gains
12/8/2005	BKBTCV	Moody's rates LabCorp notes Baa3
3/31/2005	CV	S&P: Lab Corp. unaffected
1/12/2005	CV	Lehman adds LabCorp convert to recommended portfolio on robust stock outlook
12/16/2004	CV	S&P: Lab Corp. unaffected
9/13/2004	CV	Laboratory Corp. of America put not exercised on zero-coupon notes
12/18/2003	CV	S&P: LabCorp unaffected by stock purchase
3/11/2003	CV	New Issue: Salomon sells $10.35 million 0.5% notes exchangeable for LabCorp
2/27/2003	CV	New Issue: Goldman sells $5 million 0.5% notes exchangeable for LabCorp
1/28/2003	CV	Moody's rates new LabCorp Baa3
1/15/2003	CV	Fitch rates State Street convertible AA-
11/11/2002	CV	S&P notes AES tender extension
10/4/2002	CV	Market Commentary: LabCorp, TXU slammed hard on huge sell-off after latest warnings
5/9/2002	CV	Moody's lowers WorldCom to junk

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.